Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Editas Medicine (EDIT)

$19.56 0.42 (2.10%)

17:01 EDT EDIT Stock Quote Delayed 20 Minutes

Volume:

Previous Close $19.56

Market Cap 931.14M

PE Ratio -6.99

EPS -2.8

Volume (Avg. Vol.) 537,600

Day's Range 18.95 - 20.33

52-Week Range 14.01 - 34.37

Dividend & Yield N/A (N/A)

EDIT Stock Predictions, Articles, and Editas Medicine News

From InvestorPlace
From the Web

7 Biotech Stocks to Buy and Hold in 2020

By Chris Lau, InvestorPlace Contributor Mar 16, 2020

Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.

The Top 3 Gene-Editing Stocks to Own in 2020

By Ian Cooper Mar 11, 2020

The gene-editing revolution is already here, and could be a sizable boon for investors in three of the sector's top stocks.

3 Biotech Stocks That Are Set for a Breakthrough

By Matt McCall, Editor, MoneyWire Feb 1, 2019

If you're looking for biotech stocks to buy with massive breakthrough potential in gene editing, then these three are kings among the rest.

Gene Editing is a Major Technology to Watch

By Matt McCall, Editor, MoneyWire Aug 27, 2018

Gene-editing technology is going to be a game-changer in the future, which means the time to invest in CRISPR stocks is now.

Whole Foods Market, Inc. (WFM) and Xtant Medical Holdings Inc (XTNT) Lead 13 Activist Investment Filings

By Fintel May 31, 2017

13G and 13D filings are windows into activist investor activity. Latest filings include Whole Foods Markets, Inc., and these 12 other stocks

Interesting EDIT Put And Call Options For May 22nd

From Market News Video Apr 3, 2020

Investors in Editas Medicine Inc (EDIT) saw new options become available this week, for the May 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EDIT options chain for the new May 22nd contracts and identified one put and one call contract of particular interest.

Better Buy: Editas Medicine vs Sangamo Therapeutics

From The Motley Fool Apr 1, 2020

Which of these two gene-editing companies is the better investment?

First Week of May 8th Options Trading For Editas Medicine (EDIT)

From Market News Video Mar 30, 2020

Investors in Editas Medicine Inc (EDIT) saw new options become available this week, for the May 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EDIT options chain for the new May 8th contracts and identified one put and one call contract of particular interest.

Editas (EDIT) Up 0.1% Since Last Earnings Report: Can It Continue?

From Zacks Investment Research Mar 27, 2020

Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

If You Had Bought Editas Medicine (NASDAQ:EDIT) Stock A Year Ago, You’d Be Sitting On A 12% Loss, Today

From Simply Wall St Mar 26, 2020

You can invest in an index fund if you want to make sure your returns approximately match the overall market. In contrast individual stocks will provide a wide range of<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-edit/editas-medicine/news/if-you-had-bought-editas-medicine-nasdaqedit-stock-a-year-ago-youd-be-sitting-on-a-12-loss-today/">Read More...</a></div>

Editas Medicine (EDIT) Catches Eye: Stock Jumps 9%

From Zacks Investment Research Mar 19, 2020

Editas Medicine (EDIT) saw a big move last session, as its shares jumped 9% on the day, amid huge volumes.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy